E160 - (CME) Novel Agents for Treating Major Depressive Disorder (MDD)
NEI Podcast
00:00
The Importance of Epigenetic Testing in Antidepressants
Vladimir: I'm so glad you brought the sub-lad that we think about treating depression holistically like we would any illness. We really should be looking holistically to get the best outcomes. Some of these things are such low-tech interventions, the things you've mentioned that can easily be incorporated into someone's lifestyle. You mentioned genetics. Can pharmacogenetic testing be useful in helping us pick antidepressants? Vladmir: There is some literature suggesting there are some studies indicating that pharmacogeneticTesting was advantageous.
Transcript
Play full episode
